Monografie
The role of KDM4 inhibition in targeting cancer stem cells from triple-negative breast cancer
- Sprache
-
Englisch
- Umfang
-
127 Seiten
- Identifier
-
1153029200
Thema
Krebs; Onkologie; Hochschulschrift
Beteiligte Personen und Organisationen
- Inhaltsverzeichnis
- Rechteinformation
-
Der Zugriff auf Teile des Objekts ist unbeschränkt möglich.
- Letzte Aktualisierung
-
16.08.2023, 18:26 MESZ
Objekttyp
- Monografie
Beteiligte
Ähnliche Objekte (12)
Dual targeting of FGFR1 and VEGFR1 displays antitumor efficacy in breast cancer
Characterization of human primary breast cancer stem cells reveals a partial EMT phenotype
DNA methylation array analysis identifies breast cancer associated methylation changes in peripheral blood DNA
Investigation of circulating free DNA as independent indicator of impending recurrence in former breast cancer and prognostic marker in metastatic breast cancer
Functional consequences of CHEK2 and TERT breast cancer risk variants
Comparing gene expression across different microarray platforms and RNA-seq data : application to breast cancer and pluripotent stem cells
Epigenomic profiling of lung cancer : molecular characterization of lung tumor types and lung cancer risk
miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by targeting PKA and PP2A in the context of breast cancer
The impact of interventional, minimal-invasive diagnostic on individualized primary breast cancer therapy
Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Quality of life and satisfaction after breast cancer operation
Dual targeting of FGFR1 and VEGFR1 displays antitumor efficacy in breast cancer
Characterization of human primary breast cancer stem cells reveals a partial EMT phenotype
DNA methylation array analysis identifies breast cancer associated methylation changes in peripheral blood DNA
Investigation of circulating free DNA as independent indicator of impending recurrence in former breast cancer and prognostic marker in metastatic breast cancer
Functional consequences of CHEK2 and TERT breast cancer risk variants
Comparing gene expression across different microarray platforms and RNA-seq data : application to breast cancer and pluripotent stem cells
Epigenomic profiling of lung cancer : molecular characterization of lung tumor types and lung cancer risk
miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by targeting PKA and PP2A in the context of breast cancer
The impact of interventional, minimal-invasive diagnostic on individualized primary breast cancer therapy
Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
Quality of life and satisfaction after breast cancer operation
Dual targeting of FGFR1 and VEGFR1 displays antitumor efficacy in breast cancer
Characterization of human primary breast cancer stem cells reveals a partial EMT phenotype
DNA methylation array analysis identifies breast cancer associated methylation changes in peripheral blood DNA
Investigation of circulating free DNA as independent indicator of impending recurrence in former breast cancer and prognostic marker in metastatic breast cancer
Functional consequences of CHEK2 and TERT breast cancer risk variants
Comparing gene expression across different microarray platforms and RNA-seq data : application to breast cancer and pluripotent stem cells
Epigenomic profiling of lung cancer : molecular characterization of lung tumor types and lung cancer risk
miRNA-1246 induces pro-inflammatory responses in mesenchymal stem/stromal cells by targeting PKA and PP2A in the context of breast cancer
The impact of interventional, minimal-invasive diagnostic on individualized primary breast cancer therapy
Prognostic factors in the myoepithelial-like spindle cell type of metaplastic breast cancer
The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer